Sanofi Genzyme: Rare Disease Registries

Empowering patients, clinicians, and scientists with structured data.

Sanofi Genzyme’s Therapeutics business unit develops breakthrough treatments for people diagnosed with rare diseases. Disease natural histories and monitoring progress toward treatment goals are vital to successful disease management as well as ongoing publications that extend disease knowledge. These registries have provided Genzyme, and treaters of these rare disorders, greater access to the clinical data stream. Essential’s research included on-site workflow analyses among specialized clinicians, iterative digital workflow plans, and usability testing of the software team’s implementation.